Welcome to NewSpring Capital

NewSpring Capital, based in Radnor, Pennsylvania, Short Hills, New Jersey, and Washington, D.C., is a leading provider of private equity capital focused in the Mid-Atlantic region. NewSpring Capital currently has $600 million across three distinct investment strategies through its family of funds.

Across all funds, NewSpring Capital’s investment professionals include eight partners with significant experience as private equity investors, operating managers, and industry leaders at the CEO level. The firm’s highly cohesive investment team has a strong track record of investing in both private and public transactions, collectively representing more than 100 years of experience investing over $1 billion.

All three NewSpring Capital funds work closely together. Yet each fund maintains its own dedicated senior management team, investment committee and limited partner advisory board. While in some cases the funds may co-invest, each fund operates independently, investing in non-competitive asset classes, stages, and industries.

The NewSpring Capital family of funds includes:

NewSpring Ventures provides equity capital to growth and expansion stage companies with a focus on business services, enabling technologies, and information technology.

NewSpring Health Capital provides equity capital to healthcare companies within the life sciences, healthcare services, and medical device sectors.

NewSpring Mezzanine Capital provides mezzanine capital for expansion stage and buy out opportunities in the business services, health care, information technology, and specialty manufacturing sectors.